Общие новости онкологии

OpenAI Foundation Awards $40M to UNC Lineberger to Advance Personalized Cancer Vaccines

OpenAI Foundation Awards $40M to UNC Lineberger to Advance Personalized Cancer Vaccines Oncodaily

How Long Should EV-Pembrolizumab Continue in Advanced Bladder Cancer?

How Long Should EV-Pembrolizumab Continue in Advanced Bladder Cancer? Oncology News Central

Relacorilant Combo Receives Positive CHMP Opinion in Ovarian Cancer

Healio Community to host Mentorship Networking Event

On Sept. 23, Healio Community will host its first Mentorship Networking Event at 4 p.m. EDT, featuring an opportunity to connect with a mentor and gain career advice. The free webinar includes insights from four mentors in a range of specialties: Priya Bansal, MD, clinical assistant professor at Northwestern Feinberg…

Gynecologic Cancer Awareness: Dr. Teplinsky Discusses Nursing Roles

Gynecologic Cancer Awareness: Dr. Teplinsky Discusses Nursing Roles oncnursingnews.com

Scientists discover cells that cheat death and rebuild damaged tissue

Scientists discovered a population of cells that can start the process of programmed cell death, survive it, and then help rapidly rebuild damaged tissue. Their descendants become far more resistant to future damage, revealing a mechanism that could improve healing but may also help cancers return after treatment.

Переболевшие раком рассказали о первых настораживающих симптомах

Переболевшие раком рассказали о первых настораживающих симптомах Главный Региональный

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC) BioSpace

Раскрыт механизм, позволяющий половине всех видов рака скрываться от уничтожения

Раскрыт механизм, позволяющий половине всех видов рака скрываться от уничтожения hightech.plus

Subcutaneous Amivantamab Combo is a “Clear” New Standard in EGFR+ NSCLC

За 2 года до болезни: хирург назвал первый звоночек опасного рака — пока еще не слишком поздно

За 2 года до болезни: хирург назвал первый звоночек опасного рака — пока еще не слишком поздно Хибины.ру

В Британии 20 женщин перенесли мастэктомию из-за ошибок врачей при лечении рака

В Британии 20 женщин перенесли мастэктомию из-за ошибок врачей при лечении рака Дзен

Hope & Healing Celebrates New Oncology Clinic in Morris

Hope & Healing Celebrates New Oncology Clinic in Morris WCSJ News

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC) Business Wire

Хирурги по ошибке удалили грудь 20 женщинам при лечении рака

Хирурги по ошибке удалили грудь 20 женщинам при лечении рака Life.ru